Morag Helen Stewart

This inventor holds 9 USPTO granted patents and 17 published patent applications and 3 EPO patents. Top assignees: Flagship Pioneering Innovations Vi, LLC, Children's Medical Center Corporation, Harvard College. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Morag Helen Stewart. Retrieved from https://idiyas.com/inventor/morag-helen-stewart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 17)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 7.2

ph-index = 3

Forward Citations = 28(Granted Patents)

Location History:

Tiburon, CA (US) (2023)
Boston, MA (US) (2020 - 2024)

Company Filing History:

5 out of 42

Flagship Pioneering Innovations Vi, LLC

patents

2 out of 1,073

Children's Medical Center Corporation

Intellia Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12037583 - Compositions and methods for immunooncology (2024-07-16),

2. 11891625 - Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance (2024-02-06),

3. 11851659 - Compositions and methods for immunooncology (2023-12-26),

4. 11844759 - Compositions comprising circular polyribonucleotides and uses thereof (2023-12-19),

5. 11458156 - Compositions comprising circular polyribonucleotides and uses thereof (2022-10-04),

6. 11160822 - Compositions comprising circular polyribonucleotides and uses thereof (2021-11-02),

7. 11058706 - Compositions comprising circular polyribonucleotides and uses thereof (2021-07-13),

8. 10953033 - Compositions comprising circular polyribonucleotides and uses thereof (2021-03-23),

9. 10669528 - Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance (2020-06-02),

Title: Morag Helen Stewart: Innovator in Immuno-Oncology

Introduction

Morag Helen Stewart, based in Boston, MA, is a prominent inventor with a remarkable portfolio of nine patents. Her innovative work primarily focuses on immuno-oncology and hematopoietic stem cell research, contributing significantly to advancements in these critical fields.

Latest Patents

One of her latest patents is centered around "Compositions and methods for immunooncology," which involves genome editing systems, reagents, and methods tailored for immuno-oncology applications. Another notable patent is related to "Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance." This invention outlines various methods and compositions that facilitate the production, expansion, enrichment, and maintenance of hematopoietic stem cells ex vivo. It emphasizes treating these cells with agents that modulate histone methylation, inhibit TGFβ signaling, inhibit p38 signaling, activate canonical Wnt signaling, and modulate histone acetylation, ultimately relating to the transplantation of hematopoietic stem cells.

Career Highlights

Throughout her career, Morag has worked with innovative organizations like Flagship Pioneering Innovations VI, LLC, and the Children's Medical Center Corporation. Her contributions have not only furthered scientific knowledge but have also opened new pathways in treatment methodologies.

Collaborations

Morag has collaborated with talented professionals such as Catherine Cifuentes-Rojas and Ki Young Paek. These collaborations highlight the importance of teamwork in pushing the boundaries of scientific research and development.

Conclusion

Morag Helen Stewart's contributions to the fields of immuno-oncology and hematopoietic stem cell research underline her status as a leading inventor. Her nine patents reflect her commitment to innovation and excellence, marking her as a significant figure in advancing medicine and science.

Profile summary based on public USPTO records.